ArticlePharmaceuticals (Basel, Switzerland)2016

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia.

Ashkan Emadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.